Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months

Title: Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months
Authors: Masrori, Pegah; Bentein, Hannah Vaesen; Raskin, Jo; Montagna, Massimiliano; De Picker, Livia; De Volder, Ilse; Van Schil, Paul E.; Janssens, Annelies; Mercelis, Rudy
Source: ISSN:0169-5002 ; ISSN:1872-8332 ; Lung Cancer, vol. 153, (117-119.
Publisher Information: Elsevier
Publication Year: 2021
Subject Terms: Science & Technology; Life Sciences & Biomedicine; Oncology; Respiratory System; Morvan syndrome; Thymoma; Caspr2; Encephalitis; Autoimmunity; Sleep disturbance; Autoantibodies; Humans; Lung Neoplasms; Male; Neoplasm Recurrence; Local; Thymus Neoplasms; 1103 Clinical Sciences; 1112 Oncology and Carcinogenesis; Oncology & Carcinogenesis; 3202 Clinical sciences; 3211 Oncology and carcinogenesis
Description: Morvan's syndrome (MoS) is a rare autoimmune disorder characterized by central nervous system involvement, autonomic dysfunction and peripheral nerve hyperexcitability. MoS is believed to be caused by autoantibodies targeting contactin-associated protein 2 (Caspr2), a subunit of the neuronal voltage-gated potassium channel (VGKC) complex, usually in association with thymoma, less commonly with other malignancies. This case highlights an exceptional case of severe sleep disturbances and behavioural changes due to MoS, in a patient who would present with and be treated successfully for a second relapse of thymoma 30 months later. Originally he suffered from ocular myasthenia, another autoimmune disorder, which led to diagnosis of his original thymoma and first relapse. ; status: Published
Document Type: article in journal/newspaper
Language: English
Relation: https://lirias.kuleuven.be/handle/20.500.12942/717034; https://doi.org/10.1016/j.lungcan.2021.01.012; https://pubmed.ncbi.nlm.nih.gov/33485137
DOI: 10.1016/j.lungcan.2021.01.012
Availability: https://lirias.kuleuven.be/handle/20.500.12942/717034; https://hdl.handle.net/20.500.12942/717034; https://doi.org/10.1016/j.lungcan.2021.01.012; https://pubmed.ncbi.nlm.nih.gov/33485137
Rights: info:eu-repo/semantics/restrictedAccess ; intranet
Accession Number: edsbas.93966CF7
Database: BASE